Address: Hemofarm AD, Beogradski put bb, 26300 Vršac
Tel: +381 13 803100
Production and sales of medicinal products represent the core activities successfully performed by Hemofarm for five decades already. Capital, knowledge, competence and energy have been woven in the construction of production complex. Hemofarm has achieved technological completeness. It has met the high standards of the industry in regard to the production of medicinal products. The plants have been adjusted to the current GMP requirements while the European certificates guarantee the highest level of products quality.
All forms of medicinal products are produced in Hemofarm’s factories starting from the simple ones to effervescent, pellet and Mi-O-Vial injectable forms. Medicinal product range includes almost all pharmacotherapeutical forms. By the end of the last century Hemofarm won the leading position in the domestic market through its quality and good business policy, and it is also the greatest Serbian exporter of medicinal products. The third of the overall production is exported to the markets of Russia, neighbouring countries, EU, developed countries of Africa and Middle East.
Developing its core business, Hemofarm started to establish the companies and marketing stations in 1991, so today it is present in Timisoara, Bucharest, Skopje, Ljubljana, Banjaluka, Sarajevo, Bad Homburg, Moscow, Kiev, Obninsk, Beijing, Baghdad and Washington.
The application of the state-of-the-art technology, compliance with the international standards and regulations and highly skilled personnel represent the guarantee of Hemofarm’s products quality. Hemofarm’s production is performed in the most up-to-date plants in Vršac, Dubovac, Podgorica, Šabac, Banjaluka and since recently in the Russian city Obninsk as welL.
drugs
Suzana Djordjevic, director of the Hemofarm Foundation in Serbia, explores the themes of collectivism, social care and how individual acts can have profound outcomes in today’s world. Having enjoyed a…
Ronald Seeliger, CEO of Hemofarm group, arrived in Serbia during turbulent times in CEE. Following a strict program of reinvestment, local expertise, and innovative strategies, Hemofarm surged forwards, developing into…
Milica Glisic, with over 15 years of experience in the pharma business and ten years at Wörwag Pharma, discusses the strong workforce in the Balkans, Wörwag Pharma’s mission in the…
Siniša D. Vučinić, the brains behind Aqualab Plus Systems, which holds laboratories across Serbia that offer a variety of sophisticated blood tests specifically targeted at the elderly, pregnant women and…
Ronald Seeliger, CEO of Hemofarm group, arrived in Serbia during turbulent times in CEE. Following a strict program of reinvestment, local expertise, and innovative strategies, Hemofarm surged forwards, developing into…
Sanja Ivanic, director general of the French-Serbian Chamber of Commerce, discusses the advantages of working in Serbia, the opportunities that the country offers, Serbia’s entrance into the EU, the Chamber’s…
Vera Nikolic-Dimic, executive director of the American Chamber of Commerce (AmCham) in Serbia, pinpoints the key facets of the Serbian economy that have captivated the interests of American businesses, the…
Bojan Trkulja, managing director of INOVIA, Serbia’s innovative drug manufacturers association, underlines the importance of cooperation not only between his members but also between all the key stakeholders of the…
Rather than Mr. Bugarin’s personal views, the following information contains general statements provided by the Serbian Chamber of Commerce Current trends in pharmaceutical industry The production of the medicines in…
Priorities and plans of the Ministry of Health If we entered an election year with a major reform plan, we would not succeed in putting such proposals into parliamentary procedure.…
Roche is one of the oldest multinational pharmaceutical companies here in Serbia. How do you think your history in the country gives you an advantage today as a company? We…
Pfizer is increasingly interested in emerging markets, with a focus very much on Latin America and Asia. Given this, why is Serbia exciting for Pfizer today? Serbia is interesting for…
Serbia has had an undoubtedly troubled history since the breakup of Yugoslavia in the early 1990s. A costly war and ensuing UN sanctions have left the country’s economy a few…
As the 7th largest pharma MNC worldwide, AstraZeneca is a company that needs no introduction. However, our readers would love to hear more about your operations here in Serbia… Therefore,…
See our Cookie Privacy Policy Here
